Table Of Content

Clinical Endocrinology Edited by R. N. Ciayton and J. A. H. Wass Editorial Assistant W. F. Kelly Volume 34 1991 BLACKWELL SCIENTIFIC PUBLICATIONS OXFORD LONDON EDINBURGH BOSTON MELBOURNE PARIS BERLIN VIENNA © 1991 Blackwell Scientific Publications Ltd. Authorization to photocopy for internal or personal use or the internal or personal use of specific clients is granted by Blackwell Scientific Publications Ltd for libraries and other users registered with the Copyright Clearance Center (CCC) Transactional Reporting Service, provided that the base fee of $05.00 per copy is paid directly to the CCC, 27 Congress Street, Salem, MA 01970, USA. This consent does not extend to other kinds of copying, such as copying for general distribution for advertising or promotional purposes, for creating new collective works or for resale. Special requests should be addressed to the Editor. 0300-0664/91/$05.00. Blackwell Scientific Publications Oxford London Edinburgh Boston Melbourne Paris Berlin Vienna ISSN 0300-0664 Printed in Great Britain at The Alden Press, Oxford Clinical Endocrinology (1991) 34, iii-vi Contents Volume 34, Number 1, January 1991 thyroiditis: genetic characteristics of euthyroid Graves’ ophthalmopathy: DAISUKE INOUE, Editorial KAORU SATO, MASAHIRO MAEDA, HIDETOSHI INOKO, Commentary Heterogeneity of growth hormone KIMIYOSHI TSUJI, TORU MORI and HIROO IMURA production in human pituitary cells: 3. R. E. DAVIS Use of ketoconazole in the treatment of Cushing’s The relationship between growth hormone disease and ectopic ACTH syndrome: A. TABARIN, (GH) messenger ribonucleic acid levels and hormone A. NAVARRANNE, J. GUERIN, J.-B. CORCUFF, release from individual cells derived from human M. PARNEIX and P. ROGER GH-secreting pituitary adenomas: L. J. HOFLAND, Long-term follow-up of treatment of thyrotoxicosis B. VELKENIERS, P. M. VAN KOETSVELD, by three different methods: J. A. FRANKLYN, E. L. HOOGHE-PETERS and S. W. J. LAMBERTS J. DAYKIN, Z. DROLC, M. FARMER and The pituitary gland is capable of responding to two M. C. SHEPPARD successive doses of growth hormone releasing Prevalence and follow-up of abnormal thyrotrophin hormone (GHRH): D. suRI, P. C. HINDMARSH, (TSH) concentrations in the elderly in the United D. R. MATTHEWS, C. E. BRAIN and C. G. D. BROOK Kingdom: J. v. PARLE, J. A. FRANKLYN, K. W. CROSS, Circulating levels of inhibin in pregnant women at S. C. JONES and M. C. SHEPPARD term: simultaneous disappearance with oestradiol and Increased growth hormone response to growth progesterone after delivery: L. M. KETTEL, hormone releasing hormone induced by erythropoietin S. J. ROSEFF, M. L. BANGAH, H. G. BURGER and in uraemic patients: L. CANTALAMESSA, S. S.C. YEN L. CREMAGNANI, A. ORSATTI, L. VIGNA and Effect of the new dopaminergic agonist CV 205-502 G. BUCCIANTI on plasma levels and tumour size in bromocriptine- Review Thyroid disease in relation to pregnancy: resistant prolactinomas: L. DURANTEAU, J. H. LAZARUS and S. OTHMAN P. CHANSON, A. LAVOINNE, S. HORLAIT, J. LUBETZKI Book reviews and J. M. KUHN Clinical Endocrinology Trust and study grants Testosterone-secreting virilizing adrenal adenoma with human chorionic gonadotrophin receptors and 21-hydroxylase deficiency: P. LEINONEN, T. RANTA, R. SIEGBERG, R. PELKONEN, P. HEIKKILA and Volume 34, Number 2, February 1991 A. KAHRI The relationship between sex steroids and bone Symposium on Endocrinology and Molecular Biology mineral content in women soon after the menopause: Commentary Thyroxine replacement therapy: T. D. SPECTOR, P. W. THOMPSON, L. A. PERRY, A. D. TOFT H. H. MCGARRIGLE and A. C. EDWARDS Allgrove syndrome: an autosomal! recessive syndrome The pathogenesis of the ovarian hyperstimulation of ACTH insensitivity, achalasia and alacrima: syndrome (OHS): a possible role for ovarian renin: P. S. J. MOORE, R. M. COUCH, Y. S. PERRY, A. C. M. ONG, V. EISEN, D. P. RENNIE, R. HOMBURG, E. P. SHUCKETT and J. S. D. WINTER G. C. LACHELIN, H. S. JACOBS and J. D. H. SLATER Thyroxine replacement in post-radioiodine Corticotrophin releasing hormone (CRH,_4)) hypothyroidism: C. P. BEARCROFT, G. C. TOMS, stimulates the secretion of adrenocorticotrophin, S. J. WILLIAMS, K. NOONAN and J. P. MONSON vasopressin and oxytocin but not A long-term dose-response study of somatostatin adrenocorticotrophin precursors: evidence from analogue (SMS 201-995, octreotide) in resistant petrosal sinus sampling in man: S. S. NUSSEY, acromegaly: J. A. MCKNIGHT, D. R. MCCANCE, S. R. PAGE, D. B. PETERSON, J. BYRNE, S. R. CROSBY, B. SHERIDAN, E. MCILRATH, D. R. HADDEN, A. WHITE, V. T. Y. ANG, R. JACKSON and L. KENNEDY and A. BREW ATKINSON J. S. JENKINS The diagnosis of polycystic ovaries in women with Genetic differences shown by HLA typing among oligo-amenorrhoea: predictive power of endocrine Japanese patients with euthyroid Graves’ tests: R. FOX, E. CORRIGAN, P. A. THOMAS and ophthalmopathy, Graves’ disease and Hashimoto’s M. G. R. HULL Contents High permanent plasma adrenaline levels: a marker of Effect of growth hormone therapy on thyroid status adrenal medullary disease in medullary thyroid of girls with Turner’s syndrome: G. MASSA, carcinoma: R. VISTELLE, H. GRULET, C. GIBOLD, F. DE ZEGHER and M. VANDERSCHUEREN- B. CHAUFOUR-HIGEL, B. DELEMER, R. FAY, LODEWEYCKX M. J. DELISLE and J. CARON Abnormalities in fasting circulating proinsulin Metabolic effects of pharmacological adrenergic concentration in mild gestational diabetes: blockade in phaeochromocytoma: A. J. KRENTZ, A. DORNHORST, M. DAVIES, V. ANYAOKU, P. J. HALE, P. M. HORROCKS, K. E. HESLOP, S. M. HAMPTON, R. S. ELKELES, R. W. BEARD and D. G. JOHNSTON, A. D. WRIGHT and M. NATTRASS D. G. JOHNSTON Heterogeneity of circulating TSH-receptor antibodies Episodic ACTH and cortisol secretion in normal in thyroid disease demonstrated directly by children: wW. H. B. WALLACE, E. C. CROWNE, chromatography: J. WORTHINGTON, S. M. SHALET, C. MOORE, S. GIBSON, M. D. LITTLEY P. G. H. BYFIELD and R. L. HIMSWORTH and A. WHITE Current therapy The treatment of hypercalcaemia of The impact of ovarian laser surgery on the malignancy: D. HEATH gonadotrophin secretion in women with polycystic Review Insulin action 1991: R. TAYLOR ovarian disease: W. G. ROSSMANITH, J. KECKSTEIN, K. SPATZIER and C. LAURITZEN Current therapy Management of prolactinomas: D. CUNNAH and M. BESSER Volume 34, Number 3, March 1991 237 Review Syndromes of thyroid hormone resistance: J. A. FRANKLYN 173 Commentary Should dopamine agonist treatment for 247 Book reviews prolactinomas be life-long?: G. FAGLIA 248 Notices 175 Withdrawal of bromocriptine after long-term therapy of macroprolactinomas; effect on plasma prolactin and tumour size: J. W. VAN’T VERLAAT and Volume 34, Number 4, April 1991 R. J. M. CROUGHS Iodine intake and the seasonal incidence of 249 Commentary Molecular genetics of thyrotoxicosis in New Zealand: H. C. FORD, hypochondroplasia: R. V. THAKKER L. A. JOHNSON, C. M. FEEK and J. D. NEWTON 253 The relation between pharmacokinetics and endocrine Role of peripherally infused angiotensin II on the effects of buserelin implants in patients with human hypothalamic-pituitary—adrenal axis: mastalgia: J. G. M. KLIJN, B. VAN GEEL, A. E. CALOGERO, M. C. FORNITO, A. ALIFFI, F. H. DE JONG, J. SANDOW and B. KRAUSS E. VICARI, M. L. MONCADA, F. MANTERO, P. POLOSA Attenuation of gonadotrophin release and reserve in and R. D’AGATA superovulated women by gonadotrophin surge Growth hormone, insulin-like growth factor I, insulin attenuating factor (GnSAF): I. E. MESSINIS and and C-peptide during human fetal life: in-utero study: A. TEMPLETON S. SALARDI, L. F. ORSINI, E. CACCIARI, F. RIGHETTI, Growth characteristics and response to growth S. DONATI, M. MANDINI, A. CICOGNANI and hormone therapy in patients with hypochondroplasia: L. BOVICELLI genetic linkage of the insulin-like growth factor I gene Gonadotrophin releasing hormone agonist at chromosome 12q23 to the disease in a subgroup of suppressive treatment of ovarian function decreases these patients: P. E. MULLIS, M. S. PATEL, serum LH-f and bioactive LH but maintains elevated P. M. BRICKELL, P. C. HINDMARSH and levels of LH-a: A. LEMAY and M. LOURDUSAMY C. G. D. BROOK Intravenous aminobisphosphonate in Paget’s disease: Inter-relations between growth hormone, insulin, clinical, biochemical, histomorphometric and insulin-like growth factor-I (IGF-I) and sex hormone- radiological responses: A. J. FENTON, binding globulin in acromegaly: J. M. P. HOLLY, D. H. GUTTERIDGE, G. N. KENT, R. I. PRICE, A. M. COTTERILL, R. C. JEMMOTT, D. SHEARS, R. W. RETALLACK, C. I. BHAGAT, G. K. WORTH, S. AL-OTHMAN, T. CHARD and J. A. H. WASS R. I. THOMPSON, I. G. WATSON, C. BARRY-WALSH Effects of growth hormone administration on and L. R. MATZ dehydroepiandrosterone sulphate, androstenedione, Contents v testosterone and cortisol metabolism during The effect of lithium therapy on parameters thought nutritional repletion: T. R. ZIEGLER, R. L. BARBIERI, to be involved in the development of autoimmune L. S. YOUNG, E. FERRARI-BALIVIERA and thyroid disease: R. WILSON, J. H. MCKILLOP, D. W. WILMORE G. T. CROCKET, C. PEARSON, C. JENKINS, F. BURNS, d-Fenfluramine/prolactin response throughout the A. K. BURNETT and J. A. THOMSON menstrual cycle: evidence for an oestrogen-induced Histological and biochemical distinctiveness of alteration: Vv. O’KEANE, M. O’HANLON, M. WEBB and atypical aldosterone-producing adenomas responsive T. DINAN to upright posture and angiotensin: T. J. TUNNY, A cluster of male pseudohermaphrodites with R. D. GORDON, S. A. KLEMM and D. COHN 5a-reductase deficiency in Papua New Guinea: Physiological growth hormone secretion in adult J. IMPERATO-MCGINLEY, M. MILLER, J. D. WILSON, growth hormone deficiency: comparison with normal R. E. PETERSON, C. SHACKLETON and controls: H. M. WHITEHEAD, B. AIKEN, S. LEWIS, D. C. GAJDUSEK B. SHERIDAN and D. R. HADDEN The effects on anterior pituitary hormone secretion of Phorbol ester, not growth hormone releasing factor, salmon calcitonin in healthy volunteers: consistently stimulates growth hormene release from P. J. TRAINER, J. M. W. KIRK, L. MCLOUGHLIN, somatotroph adenomas in culture: NAOYA EMOTO, R. J. TOUZEL, L. PERRY, L. H. REES and EIJI OHMURA, OSAMU ISOZAKI, TOSHIO TSUSHIMA, G. M. BESSER KAZUO SHIZUME and HIROSHI DEMURA Serum androgens in intensive-care patients: HLA Associations with Hashimoto’s thyroiditis: correlations with clinical findings: Pp. LUPPA, N. TANDON, L. ZHANG and A. P. WEETMAN R. MUNKER, D. NAGEL, M. WEBER and Production of calcitonin gene related peptide, D. ENGELHARDT calcitonin and PTH-related protein by a prostatic Glucose metabolism in patients with Cushing’s adenocarcinoma: A. SHULKES, D. R. FLETCHER, syndrome: S. B. BOWES, J. J. BENN, I. N. SCOBIE, C. RUBINSTEIN, P. R. EBELING and T. J. MARTIN A. M. UMPLEBY, C. LOWY and P. H. SONKESEN Effects of antibodies against octreotide in two patients Review The diagnosis and differential diagnosis of with acromegaly: H. @RSKOV, S. E. CHRISTENSEN, Cushing’s syndrome: P. J. TRAINER and J. WEEKE, A. KAAL and A. G. HARRIS A. GROSSMAN Megavoltage pituitary irradiation in the management Book reviews of prolactinomas: long-term follow-up: S. TSAGARAKIS, A. GROSSMAN, P. N. PLOWMAN, A. E. JONES, R. TOUZEL, L. H. REES, J. A. H. WASS Volume 34, Number 5, May 1991 and G. M. BESSER Pyridostigmine fails to increase either spontaneous or 335 Skeletal responsiveness to parathyroid hormone in GHRH-stimulated GH secretion during day or night healthy females: relationship to menopause and in growth hormone-insufficient children: oestrogen replacement: C. JOBORN, S. LIUNGHALL, J. M. W. KIRK, R. J. M. ROSS, P. J. TRAINER, K. LARSSON, E. LINDH, T. NAESSEN, L. WIDE, A. L. J. FROUD, S. C. DAVIES, M. O. SAVAGE and G. AKERSTROM and J. RASTAD G. M. BESSER Cognitive abilities in androgen-insensitive subjects: Effect of low dose iodide supplementation on thyroid comparison with control males and females from the function in potentially susceptible subjects: are dietary same kindred: J. IMPERATO-MCGINLEY, iodide levels in Britain acceptable?: c. c. cHow, M. PICHARDO, T. GAUTIER, D. VOYER and D. 1. W. PHILLIPS, J. H. LAZARUS and A. B. PARKES M. P. BRYDEN Review Wider indications for treatment with Induction of c-fos and c-myc mRNA expression by biosynthetic human growth hormone in children: immunoglobulin G from patients with Graves’ disease P. C. HINDMARSH, N. A. BRIDGES and in thyrotrophin-dependent rat thyroid cell line Cc. G. D. BROOK (FRTLS): H. HATABU, K. KASAGI, Y. IIDA, Letters to the Editors T. NOSAKA, T. MISAKI, A. HIDAKA, Y. TOKUDA, Book reviews K. ENDO, T. MORI, K. LEE, K. TSUBOI, M. HATANAKA and J. KONISHI vi Contents Volume 34, Number 6, June 1991 gonadotrophins and «-subunit in postmenopausal women: B. COUZINET, N. LAHLOU, G. THOMAS, 435 Primary localized cutaneous amyloidosis and familial J. C. THALABARD, P. BOUCHARD, M. ROGER and medullary thryroid carcinoma: J. P. FERRER, G. SCHAISON I. HALPERIN, J. I. CONGET, M. ALSINA, Male pseudohermaphroditism due to Leydig cell M. J. MARTINEZ-OSABA, J. PALOU, J. A. BOMBI and agenesia and absence of testicular LH receptors: E. VILARDELL J. MARTINEZ-MORA, J. M. SAEZ, N. TORAN, Defects in monocyte polarization and dendritic cell R. ISNARD, M. M. PEREZ-IRIBARNE, J. EGOZCUE and clustering in patients with Graves’ disease. A putative L. AUDI role for a non-specific immunoregulatory factor Comparison of the effects of ANF 99-126 and ANF related to retroviral pISE: M. TAS, M. DE HAAN- 103-126 on captopril-induced renin release in man: MEULMAN, P. J. KABEL and H. A. DREXHAGE C. C. LANG, J. J. MCMURRAY, C. MOYSES and Effect of ritanserin, specific SHT-2 antagonist, on A. D. STRUTHERS PRL secretion in normal subjects and in different The presence of cation-dependent proteases for hyperprolactinaemic conditions: P. FALASCHI, insulin-like growth factor binding proteins does not M. ROSA, A. ROCCO, R. D’URSO, A. PROIETTI and alter the size distribution of insulin-like growth G. B. MELIS factors in pregnancy: S. C. DAVIES, J. M. P. HOLLY, Reproducibility of 24-hour serum growth hormone V. J. COULSON, A. M. COTTERILL, A. F. ABDULLA, profiles in man: S. SAINI, P. C. HINDMARSH, P. G. WHITTAKER, T. CHARD and J. A. H. WASS D. R. MATTHEWS, P. J. PRINGLE, J. JONES, Current therapy The treatment of Cushing’s M. A. PREECE and C. G. D. BROOK syndrome: A. B. ATKINSON Plasma growth hormone (GH)-releasing hormone Review The role of oxytocin: present concepts: levels in patients with lung carcinoma: J. SCHOPOHL, J. S. JENKINS and S. S. NUSSEY M. LOSA, C. FREY, G. WOLFRAM, R. HUBER, Commentary Creutzfeld—Jakob disease following W. PERMANETTER, J. VON PAWEL, O. A. MULLER treatment with human pituitary hormones: M. A. and K. VON WERDER PREECE Changes in skeletal muscle and body composition after discontinuation of growth hormone treatment in 531 Book reviews growth hormone deficient young adults: 533 Notices O. M. RUTHERFORD, D. A. JONES, J. M. ROUND, C. R. BUCHANAN and M. A. PREECE 535 Author index to Volume 34 Effects of gonadotrophin releasing hormone 541 Subject index to Volume 34 antagonist and agonist on the pulsatile release of